Core Viewpoint - Sichuan Gold (001337.SZ) has successfully acquired exploration rights for the Kugez-Juebei gold mine in Xinjiang for 510 million yuan, indicating a strategic move to enhance its resource portfolio in a geologically favorable area [1] Group 1: Company Actions - On August 13, the Xinjiang Natural Resources Department announced the auction of nine exploration rights, including the geothermal survey for the summer hotel in Bole City [1] - On September 30, the company won the exploration rights for the Kugez-Juebei gold mine, which is located in a significant gold mineralization belt in China [1] Group 2: Geological Context - The exploration area is characterized by favorable geological conditions, with gold anomalies extending several kilometers and aligned with controlling structures [1] - The mineralization is influenced by northwest-southeast trending folds and faults, suggesting a high potential for mineral discovery [1]

Core Viewpoint - Sichuan Gold (001337) has successfully acquired exploration rights for the Kugezi-Juebei gold mine in Xinjiang for 510 million yuan, indicating strong potential in a key mineral-rich area of China [1] Group 1: Company Actions - On August 13, the Xinjiang Natural Resources Department announced the public offering of exploration rights for nine mining projects, including geothermal surveys [1] - On September 30, the company won the exploration rights for the Kugezi-Juebei gold mine in Xinjiang for 510 million yuan [1] Group 2: Geological Context - The exploration area is located in the Central Tianshan mineralization belt, a significant gold mining region in China [1] - The mineral body is controlled by northwest-southeast trending folds and faults, with gold anomaly zones extending several kilometers, aligning with the controlling geological structures [1] - The geological conditions for mineralization in the exploration area are favorable, suggesting substantial exploration potential [1]

证券代码：001337 证券简称：四川黄金 公告编号：2025-046 四川黄金股份有限公司 关于参与探矿权竞买及其结果的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、交易概述 （一）交易基本情况 2025 年 8 月 13 日，新疆维吾尔自治区自然资源厅委托新疆维吾尔自治区政 务服务和公共资源交易中心发布了《2025 年新疆博乐市夏尔希里酒店地热普查 等 9 个探矿权挂牌出让公告》（2025-KYQCR14）。2025 年 9 月 30 日，公司以 51,004.30 万元人民币竞得新疆高昌区库格孜-觉北金矿普查探矿权。该勘查区处 于中国重要的金矿成矿带-中天山成矿带，矿体受北西-南东向的背斜和断层控制， 勘查区金异常带长达数公里，与控矿构造的方向一致，成矿地质条件较为优越， 具有较大的找矿潜力。 （二）审议程序 按照公司战略发展规划，公司于 2025 年 9 月 22 日召开第二届董事会第十次 会议审议通过了《关于参与竞买新疆高昌区库格孜-觉北金矿普查探矿权的议案》。 董事会同意授权公司在董事会决策权限内，参与竞买新疆高昌区库格孜-觉北金 矿普 ...

证券代码：001337 证券简称：四川黄金 公告编号：2025-045 2025 年 9 月 22 日，四川黄金股份有限公司（以下简称"公司"）第二届董事会 第十次会议以通讯方式召开。本次会议通知已于 2025 年 9 月 19 日以电子邮件、 电话等方式发出。本次会议由董事长冯希尧先生主持，应到董事 12 人，实到董事 12 人，公司高级管理人员列席了本次会议。本次会议的召集、召开、表决等程序 符合《中华人民共和国公司法》及相关法律法规和《公司章程》《董事会议事规 则》的规定。 二、会议审议情况 （一）审议通过了《关于参与竞买新疆高昌区库格孜-觉北金矿普查探矿权的 议案》 表决结果：同意 12 票；反对 0 票；弃权 0 票。 董事会同意授权公司在董事会决策权限内，参与竞买新疆高昌区库格孜-觉北 金矿普查探矿权，并在董事会授权范围内缴纳保证金、确定竞买价格，按相关程 序办理竞买相关手续、签署相关协议、文件及办理其他相关具体事宜。 因董事会召开之日，实际竞买价格尚无法确定，董事会同意，如本次竞买价 格低于公司 2024 年经审计总资产的 30%，则以本次董事会决策为准；如本次竞买 价格高于公司 2024 年经 ...

Group 1 - Double-Helix Pharmaceutical announced that its associate, Changfeng Pharmaceutical, is expected to be listed on the Hong Kong Stock Exchange on October 8, 2025, with a global offering of 41.198 million shares priced at HKD 14.75 each. Double-Helix holds approximately 3.68% of Changfeng's shares, with a lock-up period of 12 months post-listing [1] - Changfeng Pharmaceutical is involved in the pharmaceutical industry, specifically in the research and development of gene-engineered drugs [2] Group 2 - Lio Corporation has submitted an application to the Hong Kong Stock Exchange for issuing H-shares and listing on the main board [3] - Lio Corporation operates in the mechanical manufacturing and digital marketing sectors [3] Group 3 - Changjiang Securities received approval from the China Securities Regulatory Commission to issue corporate bonds totaling no more than CNY 20 billion, valid for 24 months [4] - Changjiang Securities provides services such as securities and futures brokerage, financial product distribution, investment advisory, asset custody, and margin financing [4] Group 4 - Jingye Intelligent plans to acquire 51% of Hefei Shengwen Information Technology for CNY 108 million, focusing on engineering information technology and intelligent products [5][6] - Jingye Intelligent specializes in the research, development, production, and sales of special robots and intelligent equipment systems [6] Group 5 - Aimeike's subsidiary received approval for the registration of Minoxidil topical solution, a non-prescription drug for treating hair loss [7][8] - Aimeike is engaged in the research, development, production, and sales of biomedical materials and biopharmaceuticals [8] Group 6 - Dalian Heavy Industry expects a net profit of CNY 474 million to CNY 508 million for the first three quarters of 2025, representing a year-on-year increase of 19.91% to 28.52% [9] - Dalian Heavy Industry specializes in the design, manufacturing, assembly, and installation of major technical equipment [9] Group 7 - Huayou Cobalt signed supply agreements with LGES for a total of approximately 76,000 tons of ternary precursor products from 2026 to 2030 [10][11] - Huayou Cobalt focuses on the research, manufacturing, and sales of new energy lithium battery materials and cobalt new materials [11] Group 8 - Zhenjiang Co. plans to reduce its shareholding by up to 5.529 million shares, not exceeding 3% of the total share capital, due to personal funding needs [12] - Zhenjiang Co. is involved in the design, processing, and sales of wind power equipment and components [12] Group 9 - Watson Bio's subsidiary received a drug registration certificate for a 13-valent pneumococcal polysaccharide conjugate vaccine for children [14][15] - Watson Bio specializes in the research, development, production, and sales of human vaccines and biopharmaceuticals [15] Group 10 - Yikang Pharmaceutical's major shareholder plans to reduce holdings by up to 42 million shares, not exceeding 2.04% of the total share capital, due to personal funding needs [16] - Yikang Pharmaceutical is engaged in the production and sales of excipients, raw materials, finished drugs, and new energy materials [16] Group 11 - Sichuan Gold's shareholder plans to reduce holdings by up to 7.56 million shares, accounting for 1.80% of the total share capital [19] - Sichuan Gold focuses on the construction, mining, and sales of gold mines [19] Group 12 - Kangchen Pharmaceutical received approval for a clinical trial of an innovative drug for treating advanced esophageal squamous cell carcinoma [20][21] - Kangchen Pharmaceutical specializes in the manufacturing of chemical drug formulations [21] Group 13 - UCloud plans to repurchase shares worth between CNY 8 million and CNY 10 million for employee stock ownership plans [22] - UCloud provides cloud computing services centered on IT infrastructure [22] Group 14 - Woton Technology announced an adjustment to its share repurchase plan, raising the price cap to CNY 60 per share [24] - Woton Technology specializes in the research, manufacturing, and sales of separation membrane products [24] Group 15 - Five Continents Medical announced plans for shareholders to reduce holdings by up to 126,530 shares, accounting for 1.8606% of the total share capital [26] - Five Continents Medical focuses on the research, manufacturing, and sales of disposable sterile infusion medical devices [26] Group 16 - CIMC Group plans to repurchase A-shares with a total amount not exceeding CNY 5 billion [27] - CIMC Group specializes in logistics and energy equipment solutions [27] Group 17 - Zhifei Biological's subsidiary received a drug registration certificate for a trivalent influenza vaccine suitable for individuals aged 3 and above [29][30] - Zhifei Biological is involved in the research, development, production, and sales of vaccines and biological products [30]

Core Insights - The precious metals sector experienced a rise of 1.85% on September 30, with Zhongjin Gold leading the gains [1] - The Shanghai Composite Index closed at 3882.78, up 0.52%, while the Shenzhen Component Index closed at 13526.51, up 0.35% [1] Precious Metals Sector Performance - Zhongjin Gold (600489) closed at 21.93, up 3.84% with a trading volume of 1.1969 million shares and a transaction value of 2.603 billion [1] - Hengbang Shares (002237) closed at 14.97, up 2.75% with a trading volume of 530,700 shares and a transaction value of 789 million [1] - Yunnan Tin (002155) closed at 22.44, up 2.65% with a trading volume of 828,000 shares and a transaction value of 1.862 billion [1] - Shandong Gold (600547) closed at 39.33, up 0.85% with a trading volume of 570,600 shares and a transaction value of 2.246 billion [1] Capital Flow Analysis - The precious metals sector saw a net outflow of 120 million from institutional investors, while retail investors had a net inflow of 140 million [3] - Major stocks like Zhongjin Gold and Shandong Gold experienced varying levels of net inflow and outflow from different investor types [4] - For instance, Zhongjin Gold had a net inflow of 196 million from institutional investors but a net outflow of 230 million from retail investors [4]

Core Viewpoint - Several companies are planning to reduce their shareholdings, indicating potential shifts in ownership and investor sentiment in the market [1] Shareholder Reductions - Senba Sensor's actual controller's concerted action party plans to reduce holdings by no more than 1.09% [1] - Erkang Pharmaceutical's controlling shareholder intends to reduce holdings by no more than 2.04% [1] - Andeli's shareholder BVI Donghua plans to reduce holdings by no more than 1.00% [1] - Zhiyang Innovation's controlling shareholder and its concerted action party plan to reduce a total of no more than 4.225 million shares [1] - Sichuan Gold's shareholder Beijing Jinyang intends to reduce holdings by no more than 1.8% [1] - Guoji Heavy Industry's shareholders, including Bank of China Deyang Branch and Bank of China Zhenjiang Runzhou Branch, plan to reduce a total of no more than 1% [1] - Meixin Sheng's shareholder WI Harper Fund VII plans to reduce holdings by no more than 1% [1] - Yanmian Technology's actual controller and controlling shareholder Liu Yan plan to reduce a total of 1.2897% of the company's shares [1] - Jingwei Henghai's supervisor Cui Wenge plans to reduce no more than 600,000 shares [1] - New Xiangwei's shareholder Kehongxin plans to reduce holdings by no more than 1% [1] - Wujin Stainless Steel's three executives plan to reduce a total of no more than 623,400 shares [1] - Zhongrun Optical's director Lu Gaofei plans to reduce no more than 695,300 shares [1] Regulatory Actions - *ST Mubang's actual controller Liao Zhiyuan has received a notice of investigation from the China Securities Regulatory Commission [1] - Youkeshu's shareholder has also received a notice of investigation from the China Securities Regulatory Commission [1]

Core Viewpoint - The gold market is experiencing a significant upward trend, with spot gold prices reaching a historical high of $3,819.81 per ounce, driven by factors such as potential interest rate cuts by the Federal Reserve and increased demand from gold ETFs [1][2][4]. Group 1: Market Performance - On September 29, spot gold prices rose over 1%, breaking the $3,800 per ounce mark, while spot silver prices increased by 2%, reaching $47.174 per ounce, also a historical high [2]. - The A-share market saw a strong performance in the precious metals sector, with several gold-related stocks, such as Zhaojin Mining and Xiaocheng Technology, rising over 6% [2]. Group 2: Investment Drivers - Financial investment participants, including gold ETF investors and global central banks, are identified as the main sources of the current upward trend in gold prices [3]. - In September, global gold ETF holdings surged, with a notable increase of nearly 27 tons in a single day, marking the fastest growth in three years [3]. Group 3: Future Price Predictions - UBS Wealth Management predicts that gold prices could reach $3,900 per ounce by mid-2026, supported by a favorable macroeconomic narrative for precious metals [4]. - Analysts from Dongwu Securities believe that the downward trend in real interest rates and the initiation of a rate-cutting cycle by the Federal Reserve will provide substantial upward potential for gold prices [4]. Group 4: Supporting Factors - Three main factors are expected to support the upward trend in gold prices: 1. Increased demand for safe-haven assets due to economic uncertainties and geopolitical risks [4]. 2. Continued central bank purchases of gold, driven by diversification of reserves and reduced reliance on the US dollar [4]. 3. Inflation expectations, which, if they materialize, could enhance gold's value as an inflation hedge [5]. Group 5: Regional Insights - In China, despite a recent decline in gold investment demand due to a rising stock market, expectations are that ETF holdings will recover as gold prices continue to rise [5]. - The Hong Kong government's plan to expand gold reserves and establish a central clearing system for gold is anticipated to provide additional support for gold prices [5].

Group 1 - Yinglian Co., Ltd. expects a net profit of 34.5 million to 37.5 million yuan for the first three quarters of 2025, representing a year-on-year increase of 1531% to 1673% [1] - China CNR Corporation signed major contracts totaling approximately 54.34 billion yuan, accounting for 22% of its expected revenue for 2024 [1] - Shengmei Shanghai reported a total order amount of 9.072 billion yuan, a year-on-year increase of 34.1% [2] Group 2 - Fulian Precision plans to increase capital in its subsidiary Jiangxi Shenghua with a total investment of 35.63 billion yuan, which is expected to constitute a major asset restructuring [3] - Aimeike has obtained a drug registration certificate for Minoxidil topical solution, which is used for treating male pattern baldness [4] - Guolin Technology is planning to acquire 91.07% of Kailianjie’s equity for cash, which is expected to constitute a major asset restructuring [5] Group 3 - Baicheng Co. plans to purchase 55% of Shanghai Canxi Engineering Equipment Co. and will suspend trading of its stock starting September 30, 2025 [6][7] - Diaowei is planning to acquire equity in Rongpai Semiconductor and has suspended trading of its stock [8] - Xiatun New Energy signed a strategic cooperation framework agreement with Zhongwei Co. to establish a long-term partnership in the supply chain for solid-state lithium battery materials [9] Group 4 - Lingyi Zhi Manufacturing is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international strategy [10] - Baicheng Pharmaceutical received clinical trial approval for its innovative drug BIOS-0623-Z4, which targets cancer pain treatment [11] - Weide Information announced a preliminary transfer price of 40.33 yuan per share, representing a 26% discount to its closing price [12] Group 5 - Huayou Cobalt's subsidiary signed contracts with LGES for the supply of 76,000 tons of ternary precursor materials and 88,000 tons of ternary cathode materials from 2026 to 2030 [13] - Hubei Energy signed a cooperation agreement with the Xiangyang Municipal Government to invest 26.7 billion yuan in clean energy projects [14]

Group 1 - Sichuan Gold (001337.SZ) announced that its shareholder, Beijing Jinyang Mining Investment Co., Ltd., plans to reduce its holdings by a maximum of 7.56 million shares, accounting for 1.80% of the company's total share capital [1]